This is really interesting. T cell response stronger after 3 weeks but antibody response stronger after 12...
Venezuela approves Russia's single-shot COVID-19 vaccine https://www.reuters.com/business/he...sias-single-shot-covid-19-vaccine-2021-05-15/ Venezuela has approved for use Russia's single-shot Sputnik Light COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) said on Saturday. Developed by Moscow's Gamaleya Institute, the slimmed-down vaccine, which the RDIF says is 79.4% effective against COVID-19 and costs under $10 a dose, has been earmarked for export and has been billed as a way to help vaccine supplies go further in countries with high infection rates.read more Approval of the shot by Venezuela follows successful use of the two-dose Sputnik V vaccine in the country and "will help accelerate the vaccination" campaign, said Kirill Dmitriev, the head of the RDIF, which is responsible for marketing the vaccine abroad.
India producing 40 million doses of Sputnik Not sure it is their single dose. The ruskies got several different vaccines going now, like the chinese.
The universal, permanent vaccine... New vaccine could protect against all coronaviruses, prevent future pandemics https://www.wral.com/coronavirus/ne...onaviruses-prevent-future-pandemics/19682726/ Duke researchers have created a vaccine with the potential to protect against all forms of coronavirus that move from animals to humans, now and in the future. On Monday morning, Duke experts held a briefing to discuss the vaccine, which they believe could prevent future pandemics. The vaccine works by attacking a genetic sequence common to all forms of coronavirus that enables them to bind to human cells. The new vaccine has been 100% effective in non-human tests. Last week Dr. Anthony Fauci called the new research ‘potentially exciting’ and an important proof of concept. On Monday, Duke immunologists discussed their research and its implications during a video conference call. The vaccine works by taking a small part of the virus – the part that actually attaches to cells – and presents multiple copies to the immune system. “That allows the immune system to focus a response against that part of the virus, preventing the virus from being able to attach to cells and hopefully prevent subsequent infection," said Dr. Kevin Saunders, an associate professor of surgery at Duke and director of research at the Vaccine Institute. Saunders was the lead author on the new research published last week. The vaccine will bind not only to SARS-CoV-2, but also coronaviruses that circulate in animals, according to Saunders. One reason this vaccine has been able to be created so quickly is due to 20 years of work in developing an HIV vaccine, according to Dr. Barton Haynes, a professor of medicine and immunology at the Duke School of Medicine and director of the Duke Human Vaccine Institute. “We published a paper ... on a breakthrough in HIV vaccine development," said Haynes, who said it uses the same kind of technology and vaccine designs that could be used for coronavirus. "We knew that the SARS-CoV-2 virus is an RNA virus. It’s the same kind of genetic material that the HIV virus uses," said Haynes. "The HIV virus is one of the most rapidly evolving life forms that we know – because RNA viruses tend to make mistakes as they replicate. And we knew the SARS-CoV-2 would also create mutants that would escape our immune system as the immune system made antibodies against it," he said. The new vaccine technology helps prevent replication of the virus in the nose, as well as in the lungs. Haynes believes now is the time to plan for the next coronavirus pandemic or outbreak – because we’ve had two major outbreaks before COVID-19, all in the past two decades. "One in 2003, the SARS outbreak, and one in 2011, the MERS outbreak," he said. He expects there will certainly be others. "So now is the time to provide vaccines that will prepare for those, so we can now control outbreaks and prevent them from becoming pandemics in the future.”
If they could also develop one that protects against all viruses that move from Chinese labs to humans THAT WOULD BE GREAT. Currently experiencing big demand for that. Future demand anticipated. Thanking them in advance.
Not only are employees at Emergent BioSolutions incompetent -- they also stink and smell. Employees at plant that ruined millions of J&J Covid vaccine doses failed to shower, change clothes https://www.cnbc.com/2021/05/19/emp...ne-doses-failed-to-shower-change-clothes.html Some employees at the Emergent BioSolutions plant in Baltimore failed to shower or change clothes, according to a memo released Wednesday by a key House committee. It is required when working in the factory and likely played a role in ruining millions of Johnson & Johnson’s Covid-19 doses, the committee said. Inspections of the facility conducted last year also flagged problems with mold, poor disinfection of plant equipment and inadequate training of employees. Some employees at the Emergent BioSolutions plant in Baltimore failed to shower or change clothes, which is required when working in the factory and it likely played a role in ruining millions of Johnson & Johnson’s Covid-19 doses, according to a memo released Wednesday by a key House committee. Inspections of the Bayview facility conducted last year also flagged problems with mold, poor disinfection of plant equipment and inadequate training of employees, staff for the Select Subcommittee on the Coronavirus Crisis said in the memo. The committee is holding a hearing Wednesday examining the biopharmaceutical company’s role in ruining the J&J shots. Even though inspectors found poor conditions at the plant, top executives were awarded hundreds of thousands of dollars in bonuses last year and were praised by the company’s board for their leadership, according to other documents released by the committee. Emergent CEO Robert Kramer received a $1.2 million bonus last year, according to one document, while three other executives received payments of more than $400,000. The U.S. government awarded the company a $628 million contract last year to help make coronavirus vaccines. Emergent did not immediately respond to CNBC’s request for comment. The hearing Wednesday comes more than a month after the Biden administration put J&J in charge of the Baltimore plant after U.S. officials learned that Emergent, a federal contractor that had been making key ingredients for J&J and AstraZeneca, cross-contaminated ingredients for the two shots. During the hearing, Kramer said the FDA is holding over 100 million J&J Covid-19 vaccine doses for further testing. “There are a significant number of doses that we’ve manufactured. Again, we manufacture the bulk drug substances,” Kramer told lawmakers. “It has been reported in a number of news agencies that there are probably over 100 million doses of the J&J vaccine that we’ve manufactured that are now being evaluated by the FDA for potential release and availability.” An inspection by the Food and Drug Administration later found the plant was unsanitary and unsuitable to manufacture the shots. In a 13-page report, inspectors wrote that the facility used to manufacture the vaccine was “not maintained in a clean and sanitary condition” and was “not of suitable size, design, and location to facilitate cleaning, maintenance, and proper operations.” FDA inspectors said paint was observed to be peeling in multiple areas and walls were damaged that could impact Emergent’s “ability to adequately clean and disinfect.” They also noted that employees did not follow standard operating procedures in handling waste or vaccine manufacturing materials to ensure they weren’t contaminated. The facility has not been authorized by the FDA to manufacture or distribute Johnson & Johnson’s Covid-19 vaccine, and none of the doses manufactured at the plant have been distributed for use in the United States. Emergent has agreed to pause production of materials until the issues the FDA identified are resolved. Emergent said at the time it was committed to working with the FDA and J&J to fix the problems. “While we are never satisfied to see shortcomings in our manufacturing facilities or process, they are correctable and we will take swift action to remedy them,” it said in a statement on April 21.
100 million doses of Johnson & Johnson's vaccine need to be checked for contamination and may need to be thrown out https://www.businessinsider.com/jj-doses-from-baltimore-plant-need-checked-for-contamination-2021-5 Emergent BioSolutions CEO Robert Kramer said that 100 million doses of the Johnson & Johnson vaccine are on hold. They are potentially contaminated and may need to be discarded. The New York Times reported last month that the facility may have jeopardized 62 million of J&J's COVID-19 vaccine doses. Emergent BioSolutions CEO Robert G. Kramer admitted to the House of Representatives on Wednesday that more than 100 million doses of the Johnson & Johnson vaccine are on hold and possibly contaminated. It was the first time that Kramer admitted the high figure of potentially spoiled vaccines after The New York Times reported last month that the facility may have jeopardized 62 million of Johnson & Johnson's COVID-19 vaccine doses, after ruining 15 million doses of the vaccine through cross-contamination with ingredients for AstraZeneca's vaccine. "No one is more disappointed than we are that we had to suspend our 24/7 manufacturing of new vaccine," Kramer told members of the House Select Subcommittee on the Coronavirus Crisis. The Subcommittee is investigating the company and its factory mishaps. "I apologize for the failure of our controls," Kramer added. Members asked questions about whether Kramer used political connections to win government contracts for vaccine production at the company's facilities. The millions of possibly contaminated Johnson & Johnson COVID-19 vaccine doses haven't been distributed to the public. A representative for Johnson & Johnson told Insider that, "The quality and safety of our COVID-19 vaccine are paramount. We continue to work with the US Food & Drug Administration and with Emergent, in order to secure Emergency Use Authorization in the US for drug substance manufactured at Emergent Bayview as quickly as possible."
I find it so interesting that it is plausible this virus came from a lab in China and it’s also pretty plausible it was being tinkered with by Chinese scientists (how we ended up with a respiratory illness that presents rabies-like symptoms) and there are still people who would rather get the virus than take the vaccine. Unbelievable to me.
Yep... we have a virus that kills 2 out of 100 people with proven cases. However we have a vaccine where zero people across the face of the earth have died from COVID who got the vaccine -- with over 1.5 billion shots given worldwide. Yet we have anti-vaxxers who won't take the vaccine, don't believe in science and rather die of COVID. Unbelievable.